Corrigendum to “Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia” J Clin Lipidol 11 (2017) 1338-1346 (Journal of Clinical Lipidology (2017) 11(6) (1338–1346.e7), (S1933287417304415), (10.1016/j.jacl.2017.08.016))

Joep C. Defesche, Claudia Stefanutti, Gisle Langslet, Paul N. Hopkins, Werner Seiz, Marie T. Baccara-Dinet, Sara C. Hamon, Poulabi Banerjee, John J. P. Kastelein

Research output: Contribution to journalErratum/CorrigendumAcademic


The authors regret that the row labels for the following data in Table 1 were transposed: ApoB and non-HDL-C; and TG and Lp(a). The authors would like to apologise for any inconvenience caused.
Original languageEnglish
Pages (from-to)742
Number of pages1
JournalJournal of clinical lipidology
Issue number5
Publication statusPublished - 1 Sept 2020

Cite this